Exhibit 107
Calculation of Filing Fee Tables
F-3
(Form Type)
ADC Therapeutics SA
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
| Newly Registered Securities |
| Fees to be Paid | Equity | Common Shares | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Debt | Debt Securities | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Other | Warrants | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Other | Subscription Rights | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Other | Purchase Contracts | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Other | Units | Rule 457(o) | (1) | (1) | (1) | (1) | (1) | | | | |
| Fees to be Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | Rule 457(o) | (1) | (1) | $300,000,000 | 0.00011020 | $33,060 | | | | |
| Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | | | | |
| Carry Forward Securities |
| Carry Forward Securities | N/A | N/A | N/A | N/A | | N/A | | | N/A | N/A | N/A | N/A |
| | Total Offering Amounts | | $300,000,000 | | $33,060 | | | | |
| | Total Fees Previously Paid | | | | — | | | | |
| | Total Fee Offsets | | | | $30,662.75 (2) | | | | |
| | Net Fee Due | | | | $2,397.25 | | | | |
(1) Omitted pursuant to General Instruction II.C to Form F-3. The amount to be registered consists of up to $300,000,000 of an indeterminate amount of common shares, debt securities, warrants, subscription rights, purchase contracts and/or units that may be offered and sold from time to time in one or more offerings.
(2) See Note (1) and (2) under Table 2 below.
Table 2: Fee Offset Claims and Sources
| | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Rules 457(b) and 0-11(a)(2) |
| Fee Offset Claims | | N/A | N/A | N/A | | N/A | | | | | |
| Fee Offset Sources | N/A | N/A | N/A | | N/A | | | | | | N/A |
| Rule 457(p) |
| Fee Offset Claims | ADC Therapeutics SA | F-3ASR | 333-256686 (1) | June 1, 2021 | | $8,842.75 | Equity | Common Shares | 5,558,318 | $120,726,666.96 | |
| Fee Offset Sources | ADC Therapeutics SA | F-3ASR | 333-256686 (1) | | June 1, 2021 | | | | | | $13,171.28 |
| Fee Offset Claims | ADC Therapeutics SA | F-3ASR | 333-256807 (2) | June 4, 2021 | | $21,820 | Equity | Common Shares | N/A | $200,000,000 | |
| Fee Offset Sources | ADC Therapeutics SA | F-3ASR | 333-256807 (2) | | June 4, 2021 | | | | | | $21,820 |
(1) The Registrant has terminated the offering of securities under such registration statement. No securities were sold pursuant to the registration statement. Therefore, $13,171.28 of filing fees paid in connection with the registration statement are available for offsetting other filing fees when permitted by the Securities Act and the Exchange Act. The Registrant previously used the registration statement as a fee offset source to claim offset amounts of $2,843.04 in connection with its Registration Statement on Form F-3 (File No. 333-267293), $812.33 in connection with its Registration Statement on Form F-3 (File No. 333-267295) and $673.16 in connection with its Tender Offer Statement on Schedule TO (File No. 005-91517).
(2) The Registrant has terminated the offering of securities under such registration statement. No securities were sold pursuant to the registration statement, other than for which filing fees were made on a pay-as-you-go basis pursuant to Rule 456(b) and paid at the time of the filing of a prospectus supplement pursuant to Rule 424(b). Therefore, $21,820 of filing fees paid in connection with the registration statement are available for offsetting other filing fees when permitted by the Securities Act and the Exchange Act.
